Merck: FDA whistleblower's video testimony goes beyond limits
NEW ORLEANS - Some video testimony for federal Vioxx trials by FDA whistle blower Dr. David Graham goes beyond anything he has said previously and shouldn't be heard by jurors, attorneys for manufacturer Merck & Co. said.
That includes an allegation that Merck dragged its feet about changing the label on the once-popular painkiller to warn it might increase the chance of heart attacks, according to a 22-page document added to the court record this week
· Read The Full Vioxx Article From Fort Worth Star Telegram -->
·
Read All Vioxx (Rofecoxib) News Stories -->